1419603-32-9

Basic information

• Product Name: 5-bromo-N-phenylpyrimidine-2-carboxamide
• Synonyms: 5-bromo-N-phenylpyrimidine-2-carboxamide
• CAS NO: 1419603-32-9
• Molecular Weight: 278.108
• Mol File: 1419603-32-9.mol
• Article Data: 5

Chemical Properties

• CAS DataBase Reference: 5-bromo-N-phenylpyrimidine-2-carboxamide(CAS DataBase Reference)
• NIST Chemistry Reference: 5-bromo-N-phenylpyrimidine-2-carboxamide(1419603-32-9)
• EPA Substance Registry System: 5-bromo-N-phenylpyrimidine-2-carboxamide(1419603-32-9)

Safety Data

• Hazardous Substances Data: 1419603-32-9(Hazardous Substances Data)

Upstream product

• 37131-87-6 5-bromo-2-pyrimidinecarboxylic acid 
• 62-53-3 aniline 
• 1013335-78-8 5-bromopyridine-2-carboxylic acid chloride 

Downstream Products

• 1419603-34-1 5-bromo-N-phenyl-N-((2-(trimethylsilyl)ethoxy)methyl)pyrimidine-2-carboxamide 
• 1419603-36-3 N-phenyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-N-((2-(trimethylsilyl)ethoxy)-methyl)pyrimidine-2-carboxamide 
• 1419603-38-5 methyl 2-(2-(phenyl((2-(trimethylsilyl)ethoxy)methyl)carbamoyl)pyrimidin-5-yl)acrylate 
• 1419603-40-9 methyl 2-(2-(phenyl((2-(trimethylsilyl)ethoxy)-methyl)carbamoyl)pyrimidin-5-yl)propanoate 
• 1419603-42-1 2-(2-(phenylcarbamoyl)pyrimidin-5-yl)propanoic acid 
• 1421472-32-3 5-(1-((2-(4-methylpiperidin-1-yl)-6-(trifluoromethyl)pyridin-3-yl)methylamino)-1-oxopropan-2-yl)-N-phenylpyrimidine-2-carboxamide 

Relevant articles and documents

KINASE INHIBITOR COMPOUNDS AND COMPOSITIONS AND METHODS OF USE

Disclosed are kinase inhibitor compounds having the following structure: (I), or a stereoisomer, pharmaceutically acceptable salt, oxide, or solvate thereof, where R1, R2, R3,R4, R5, R6, N-Ar, X, Y, Z, and AA are as defined herein. Also disclosed are compositions containing the kinase inhibitor compounds, methods of inhibiting activity of a kinase in a cell, methods of increasing cell proliferation in a population of pancreatic beta cells, methods of treating a subject for a condition associated with insufficient insulin secretion, and methods of treating a subject for a neurological disorder.

Substituted Heteroaromatic Pyrazole-Containing Carboxamide and Urea Compounds as Vanilloid Receptor Ligands

Substituted heteroaromatic pyrazole-containing carboxamide and urea compounds as vanilloid receptor ligands, pharmaceutical compositions containing these compounds and also to a method of using these compounds for treating and/or inhibiting pain and further diseases and/or disorders.

SUBSTITUTED HETEROAROMATIC PYRAZOLE-CONTAINING CARBOXAMIDE AND UREA DERIVATIVES AS VANILLOID RECEPTOR LIGANDS

The invention relates to substituted heteroaromatic pyrazole-containing carboxamide and urea derivatives as vanilloid receptor ligands, to pharmaceutical compositions containing these compounds and also to these compounds for use in the treatment and/or prophylaxis of pain and further diseases and/or disorders.